4//SEC Filing
MENDLEIN JOHN 4
Accession 0001209191-22-034554
CIK 0001434316other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:49 PM ET
Size
5.2 KB
Accession
0001209191-22-034554
Insider Transaction Report
Form 4
MENDLEIN JOHN
Director
Transactions
- Sale
Common Stock
2022-06-03$22.79/sh−1,364$31,086→ 158,091 total
Footnotes (2)
- [F1]Required number of shares sold by the reporting person to cover tax obligations in connection with the vesting of 2,681 shares of Common Stock underlying RSUs granted to the reporting person on June 2, 2021. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]Represents the weighted average sale price of the shares sold from $22.53 to $22.92 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001238362
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 4:49 PM ET
- Size
- 5.2 KB